← Back to Clinical Trials
Recruiting NCT06781424

NCT06781424 University of Central Florida BEEAST

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06781424
Status Recruiting
Phase
Sponsor University of Central Florida
Condition Biospecimen Donation
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2025-01-13
Primary Completion 2075-01-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2025-01-13 with a primary completion date of 2075-01-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).

Eligibility Criteria

Inclusion Criteria: * Primary Enrollees: adults, ages 18 and older, and persons who travel (such as space travel) or live in extreme environments (such as Antarctica). * Secondary Enrollees: Referred adult family members (such as siblings and spouses) of primary enrollees. * Tertiary Enrollees: Adult persons from the general public can enroll to serve as matching controls. Tertiary enrollees will be screened based on age, gender, race and ethnicity, country of residence, disease/ conditions and employment history. * Pregnant women may choose to enroll. Exclusion Criteria: * adults unable to consent, * minors (under age 18) * prisoners

Contact & Investigator

Central Contact

Britney-Ann Wray, BS, CTBS, CCRP

✉ britney-ann.wray@ucf.edu

📞 4072668742

Frequently Asked Questions

Who can join the NCT06781424 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Biospecimen Donation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06781424 currently recruiting?

Yes, NCT06781424 is actively recruiting participants. Contact the research team at britney-ann.wray@ucf.edu for enrollment information.

Where is the NCT06781424 trial being conducted?

This trial is being conducted at Orlando, United States.

Who is sponsoring the NCT06781424 clinical trial?

NCT06781424 is sponsored by University of Central Florida. The trial plans to enroll 10,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology